Patents by Inventor Max Woisetschlager

Max Woisetschlager has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120276104
    Abstract: The invention relates to an antibody having at least two specificities to bind a glycoepitope and a receptor of the erbB class on the surface of a tumor cell, thereby crosslinking the glycoepitope and the receptor, which antibody has apoptotic activity effecting cytolysis independent of NK cells, a method of producing such antibody and its use as a therapeutic.
    Type: Application
    Filed: March 29, 2012
    Publication date: November 1, 2012
    Applicant: f-star Biotechnologische Forschungs-und Entwicklungsges.m.b.H.
    Inventor: Max Woisetschlager
  • Patent number: 7759357
    Abstract: An amine, which is substituted by phenyl-substituted pyrimidin; and phenyl; and a third substituent and its use as an immunoglobulin E (IgE) inhibitor.
    Type: Grant
    Filed: May 23, 2007
    Date of Patent: July 20, 2010
    Assignee: Novartis AG
    Inventors: Murty Bulusu, Peter Ettmayer, Klaus Weigand, Max Woisetschlager
  • Publication number: 20070281956
    Abstract: An amine, which is substituted by phenyl-substituted pyrimidin; and phenyl; and a third substituent and its use as an immunoglobulin E (IgE) inhibitor.
    Type: Application
    Filed: May 23, 2007
    Publication date: December 6, 2007
    Inventors: Murty Bulusu, Peter Ettmayer, Klaus Weigand, Max Woisetschlager
  • Publication number: 20050119255
    Abstract: An amine, which is substituted by phenyl-substituted pyrimidin; and phenyl; and a third substituent and its use as an immunoglobulin E (IgE) inhibitor.
    Type: Application
    Filed: January 31, 2003
    Publication date: June 2, 2005
    Inventors: Murty Bulusu, Peter Ettmayer, Klaus Weigand, Max Woisetschlager